Page 2 - Seth Lederman News Today

Becoming a business owner will allow you more freedom over your decisions, income and time spent, but it does not come without hard work and putting in the hours. 

New Hope For Fibromyalgia Patients: Tonix Details Results Of Second ...

By Daniella Parra Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) said it showed additional safety and tolerability data, marking the second positive Phase 3 study assessing TNX-102 SL for fibromyalgia management. Tonix said the study met its primary endpoint, demonstrating statistically significant and clinically meaningful daily pain reduction over placebo. The results also revealed a favorable […]

A Fatburger franchisee in Los Angeles reveals survival strategies as California chains brace for $20 an hour wage for fast food workers in April.

Even with a proven business model and plan, there will likely be challenges along the way.

Tonix Pharmaceuticals CEO Dr Seth Lederman shares groundbreaking news during an interview with Steve Darling from Proactive. The company has achieved highly positive results in their clinical trial...

Tonix recently reported results from second positive Phase 3 trial of Tonmya™ for the management of fibromyalgia In the U.S., New Drug Application (NDA) submission to the FDA planned for the second half of 2024 In Japan, China and most countries in Europe cyclobenzaprine is a New Chemical Entity CHATHAM, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of de...

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Dr. Seth Lederman joined Steve Darling from Proactive to delve into the significant development involving the U.S....

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Dr. Seth Lederman joined Steve Darling from Proactive to delve into the significant development involving the U.S....

Tonix Pharmaceuticals CEO Dr Seth Lederman joined Steve Darling from Proactive to delve into the significant development involving the US Food and Drug Administration s clearance of the...